Cognitive Behavioral Therapy in Prodromal Psychosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|4|558-565

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.4, 2012-02, pp. : 558-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stress and the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 527-533

Bentham Science Publishers

Access to resources Recommend Favorite

Anandamide Dysfunction in Prodromal and Established Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5188-5193

Bentham Science Publishers

Access to resources Recommend Favorite

Philosophical Issues in the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 596-605

Bentham Science Publishers

Access to resources Recommend Favorite

Feasibility of Dissemination of Cognitive Behavioral Therapy to Texas Community Mental Health Centers

By Lopez Molly  

The Journal of Behavioral Health Services & Research, Vol. 38, Iss. 1, 2011-01 ,pp. : 91-104

Springer Publishing Company

Access to resources Recommend Favorite

D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy for Anxiety Disorders: An Update

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5659-5662

Bentham Science Publishers

Access to resources Recommend Favorite